Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor 0 16.09.2024 15:09 Fiercebiotech.com Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor ntaylor Mon, 09/16/2024 - 08:09
